PT1212312E - Novos derivados de flavonas xantonas e cumarinas - Google Patents

Novos derivados de flavonas xantonas e cumarinas

Info

Publication number
PT1212312E
PT1212312E PT00958505T PT00958505T PT1212312E PT 1212312 E PT1212312 E PT 1212312E PT 00958505 T PT00958505 T PT 00958505T PT 00958505 T PT00958505 T PT 00958505T PT 1212312 E PT1212312 E PT 1212312E
Authority
PT
Portugal
Prior art keywords
xantonas
cumarinas
compounds
derivatives
useful
Prior art date
Application number
PT00958505T
Other languages
English (en)
Portuguese (pt)
Inventor
Ezio Bompardelli
Piero Valenti
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of PT1212312E publication Critical patent/PT1212312E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
PT00958505T 1999-09-03 2000-08-28 Novos derivados de flavonas xantonas e cumarinas PT1212312E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9920912.4A GB9920912D0 (en) 1999-09-03 1999-09-03 Novel derivatives of flavones,xanthones and coumarins

Publications (1)

Publication Number Publication Date
PT1212312E true PT1212312E (pt) 2003-08-29

Family

ID=10860348

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00958505T PT1212312E (pt) 1999-09-03 2000-08-28 Novos derivados de flavonas xantonas e cumarinas

Country Status (20)

Country Link
US (1) US6608089B2 (enExample)
EP (1) EP1212312B1 (enExample)
JP (1) JP4782337B2 (enExample)
KR (1) KR100819575B1 (enExample)
CN (1) CN1229370C (enExample)
AT (1) ATE236147T1 (enExample)
AU (1) AU775790B2 (enExample)
CA (1) CA2382129C (enExample)
CZ (1) CZ300939B6 (enExample)
DE (1) DE60001974T2 (enExample)
DK (1) DK1212312T3 (enExample)
ES (1) ES2195933T3 (enExample)
GB (1) GB9920912D0 (enExample)
HU (1) HUP0202578A3 (enExample)
NO (1) NO327911B1 (enExample)
PL (1) PL211887B1 (enExample)
PT (1) PT1212312E (enExample)
RU (1) RU2252221C2 (enExample)
SK (1) SK286402B6 (enExample)
WO (1) WO2001017985A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020500A2 (en) 2000-09-01 2002-03-14 Icos Corporation Materials and methods to potentiate cancer treatment
PL205635B1 (pl) * 2001-04-09 2010-05-31 Inst Farmaceutyczny Nowe pochodne genisteiny i zawierające je środki farmaceutyczne
JP4664597B2 (ja) 2002-04-17 2011-04-06 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
ATE423110T1 (de) 2002-07-17 2009-03-15 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen
EP1553911B1 (en) * 2002-08-02 2010-06-23 The Ohio State University Research Foundation 2-heterosubstituted 3-aryl-4-h-1-benzopyran-4-ones as novel therapeutics in breast cancer
WO2004024086A2 (en) * 2002-09-13 2004-03-25 Cytokinetics, Inc. Compounds, compositions and methods
KR20050095859A (ko) * 2003-02-04 2005-10-04 가부시키가이샤 야쿠루트 혼샤 유방암 내성 단백 저해제
US8404681B2 (en) 2003-03-24 2013-03-26 Luitpold Pharmaceuticals, Inc. Xanthones, thioxanthones and acridinones as DNA-PK inhibitors
JP2007507539A (ja) * 2003-10-06 2007-03-29 サイトキネティクス・インコーポレーテッド 化合物、組成物及び方法
GB0412769D0 (en) 2004-06-08 2004-07-07 Novartis Ag Organic compounds
GB0412768D0 (en) * 2004-06-08 2004-07-07 Novartis Ag Organic compounds
FR2929276B1 (fr) * 2008-04-01 2010-04-23 Servier Lab Nouveaux derives de diosmetine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN101497593B (zh) * 2009-03-18 2011-09-21 华南理工大学 5-羟基香豆素和吡喃型香豆素类化合物及合成方法与应用
EP2560652A4 (en) * 2010-04-23 2013-08-14 Kineta Inc ANTIVIRAL CONNECTIONS
CN101985449B (zh) * 2010-09-28 2012-08-22 中山大学 一种香豆素衍生物及其制备方法和作为抗癌药物的用途
CN103113340B (zh) * 2013-01-21 2015-08-19 四川大学 一类金雀异黄酮烷基胺类化合物、其制备方法和用途
CN103232462B (zh) * 2013-05-13 2016-03-02 湖北科技学院 香豆素-吡咯类化合物的合成方法
CN103408554B (zh) * 2013-07-31 2015-07-08 西安交通大学 一种具有降高血压活性的吡咯香豆素类化合物及制备方法
CN104274455B (zh) * 2014-09-24 2018-04-27 山东理工大学 含苄基哌嗪槲皮素衍生物制法及其对胃黏膜保护作用
CN107641109B (zh) * 2017-10-16 2019-05-24 厦门大学 一种类黄酮化合物及其制备方法和应用
CN107602520B (zh) * 2017-10-16 2019-06-14 厦门大学 一种含哌嗪环的类异黄酮化合物及其制备方法和应用
KR102109151B1 (ko) 2018-06-28 2020-05-11 영남대학교 산학협력단 잔톤 유도체의 신규한 제조방법, 이로 제조된 신규한 잔톤 유도체 및 이들을 포함하는 조성물
CN110156735B (zh) * 2019-04-23 2023-05-12 天津国际生物医药联合研究院 芒柄花黄素衍生物及其制备方法和应用
CN110240579B (zh) * 2019-06-10 2023-03-31 中国科学院成都有机化学有限公司 一种多取代γ-丁内酯类化合物、制备方法及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3513198A (en) * 1965-10-22 1970-05-19 Hoffmann La Roche Aryloxy- and arylthio-acetylenic amines and the salts thereof
FR2378519B1 (enExample) * 1976-11-24 1982-08-06 Unicler
JPH03163017A (ja) * 1989-08-24 1991-07-15 Nisshin Flour Milling Co Ltd 抗癌活性増強剤
US5023341A (en) 1989-09-19 1991-06-11 Allergan, Inc. Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
US5399561A (en) 1989-09-19 1995-03-21 Allergan, Inc. Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
JP2514500B2 (ja) * 1991-09-14 1996-07-10 呉羽化学工業株式会社 多剤耐性抑制剤及び発現阻害剤
US5663179A (en) * 1992-07-10 1997-09-02 Laboratoires Glaxo Sa Certain isoquinoline derivatives having anti-tumor properties
DE4323409A1 (de) * 1993-07-13 1995-01-19 Boehringer Mannheim Gmbh Verwendung von Cumarinen und Carbostyrilen als PLA¶2¶-Inhibitoren, neue Cumarine und Carbostyrile, Verfahren zu ihrer Herstellung und Arzneimittel
US5852033A (en) * 1995-06-29 1998-12-22 Pharma Mar, S.A. Methods of treatment using lamellarin-class alkaloids
JPH1036260A (ja) * 1996-07-18 1998-02-10 Mitsui Norin Kk 抗ガン剤の効力増強方法

Also Published As

Publication number Publication date
CZ300939B6 (cs) 2009-09-16
DE60001974T2 (de) 2004-02-19
US6608089B2 (en) 2003-08-19
NO20021050L (no) 2002-05-03
PL211887B1 (pl) 2012-07-31
KR100819575B1 (ko) 2008-04-04
SK286402B6 (sk) 2008-09-05
DE60001974D1 (de) 2003-05-08
CA2382129A1 (en) 2001-03-15
AU7000000A (en) 2001-04-10
HUP0202578A2 (hu) 2002-11-28
ES2195933T3 (es) 2003-12-16
DK1212312T3 (da) 2003-07-21
EP1212312A1 (en) 2002-06-12
RU2252221C2 (ru) 2005-05-20
HUP0202578A3 (en) 2005-02-28
NO20021050D0 (no) 2002-03-01
CZ2002785A3 (cs) 2002-06-12
NO327911B1 (no) 2009-10-19
WO2001017985A1 (en) 2001-03-15
SK3092002A3 (en) 2003-10-07
US20020183318A1 (en) 2002-12-05
JP2003508524A (ja) 2003-03-04
KR20020030801A (ko) 2002-04-25
HK1043368A1 (en) 2002-09-13
PL356699A1 (en) 2004-06-28
ATE236147T1 (de) 2003-04-15
CA2382129C (en) 2010-07-06
EP1212312B1 (en) 2003-04-02
CN1229370C (zh) 2005-11-30
JP4782337B2 (ja) 2011-09-28
CN1371371A (zh) 2002-09-25
GB9920912D0 (en) 1999-11-10
AU775790B2 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
DE60001974D1 (de) Derivate von flavonen, xanthonen und kumarinen
TW200505902A (en) Cannabinoid receptor ligands
GB0022438D0 (en) Organic Compounds
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
DK1200412T3 (da) Antiproliferative imidazolforbindelser
DE69908819D1 (de) Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
TW200635923A (en) Tricyclic heterocycles, their manufacture and use as pharmaceutical agents
TR200200717T2 (tr) Terapötik kinazolin türevleri.
GB0119249D0 (en) Organic compounds
HUP0400200A3 (en) Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof
DE602004014163D1 (de) Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken
TW200624431A (en) Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
NO20020282L (no) Nytt difenyl-piperidinderivat
DE60229287D1 (de) Pharmazeutische zubereitung zur oralen verwendung von heparin und seinen derivaten
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
ATE326451T1 (de) Chinazolin derivate und therapeutische verwendungen davon
IL165086A (en) Pyridyl cyanoguanidines, pharmaceutical compositions comprising them and uses thereof for the preparation of medicaments
SE9803107D0 (sv) Novel Compunds
TW200612914A (en) Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents
ITMI992736A0 (it) Composizioni farmaceutiche per la somministrazione localizzata nel cav o orale di farmaci antiinfiammatori non stereoidei utili per la terapi
TW200633701A (en) Thioether derivatives, their manufacture and use as pharmaceutical agents
ZA200110073B (en) 14β-H-Sterols, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments.
DK1439885T3 (da) Forenklede sarcodictynderivater som antitumormidler